Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Lung Cancer
Interventions: DRUG: filgrastim, TBO-filgrastim or pegfilgrastim
Sponsor: Biologics & Biosimilars Collective Intelligence Consortium
Collaborators: Henry Ford Health System|Aetna, Inc.|Amgen|College of Pharmacy, University of Nebraska College|College of Pharmacy, University of New England|HealthPartners Institute|Momenta Pharmaceuticals, Inc.|Harvard Pilgrim Health Care